High PPT1 expression predicts poor clinical outcome and PPT1 inhibitor DC661 enhances sorafenib sensitivity in hepatocellular carcinoma

Overview of attention for article published in Cancer Cell International, March 2022

Altmetric Badge

About this Attention Score

In the top 25% of all research outputs scored by Altmetric
High Attention Score compared to outputs of the same age (85th percentile)
Good Attention Score compared to outputs of the same age and source (78th percentile)

So far, Dimensions has found 16 publications that cite this research output.

Article in FEBS Letters (April 2024)

Article in European Journal of Medicinal Chemistry (April 2024)

Article in ACS Omega (February 2024)

This page shows the most recent citations of this research output.

Click here to find out how to access more activity.